XORTX Therapeutics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
XRTX Nasdaq 2834 www.xortx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for XORTX Therapeutics Inc.

XORTX Announces USD $925,000 Private Placement - Jun 26th, 2025 5:00 am
XORTX Announces USD $3 Million Offering - May 19th, 2025 5:00 am
XORTX Provides Update on FDA Type B Meeting Request - Apr 30th, 2025 5:00 am
XORTX Announces Grant of European Patent - Apr 28th, 2025 5:00 am
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Apr 17th, 2025 5:45 pm
XORTX Announces Update for Discussion with the FDA - Mar 19th, 2025 5:00 am
XORTX Commences Gout Program NDA Discussions with the FDA - Feb 24th, 2025 5:00 am
XORTX to Present at Microcap Conference - Jan 29th, 2025 5:00 am
XORTX Announces Change of Auditor - Jan 17th, 2025 3:00 pm
XORTX Adds Late Stage Gout Program to Pipeline - Jan 6th, 2025 5:00 am
XORTX Strengthens Executive Team - Dec 19th, 2024 5:00 am
XORTX Announces Presentation at the Rare and Genetic Disease Summit - Dec 12th, 2024 7:17 am
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 - Oct 24th, 2024 5:00 am
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - Oct 18th, 2024 2:00 pm
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - Oct 17th, 2024 6:00 am
XORTX Initiates Precision Medicine Program - Oct 9th, 2024 3:00 am
XORTX Announces Results of Annual and Special Meeting of Shareholders - Sep 13th, 2024 5:00 am
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A - Sep 12th, 2024 3:30 pm
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders - Sep 6th, 2024 3:30 pm
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders - Sep 3rd, 2024 10:30 am